Business
SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce
SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025.
About this update from Senestech, Inc.
[{"type":"text","content":"SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025.","length":248,"tagName":"p"},{"type":"image","alt":"SenesTech, Inc. is a pioneer in fertility control solutions for managing rodent populations. (PRNewsfoto/SenesTech, Inc.)","displaySize":"","headline":null,"caption":"SenesTech, Inc. is a pioneer in fertility control solutions for managing rodent populations. (PRNewsfoto/SenesTech, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":56,"url":"https://media.zenfs.com/en/prnewswire.com/f9358a298cf18da745be407dc7987d6e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XA_HpDcDuVrEv9YnblyoCQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTk5O2NmPXdlYnA-/https://media.zenfs.com/en/prnewswire.com/f9358a298cf18da745be407dc7987d6e","width":400,"height":56}},"href":"https://mma.prnewswire.com/media/1503420/SenesTech_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"2025 Highlights","length":15,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of EvolveĀ® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate revenue would have increased by approximately 30%. As the transition becomes fully integrated, direct Amazon management is expected to meaningfully enhance both revenue and operating margins in the future.","length":533,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross profit margin was 62.5% in 2025, compared to 54.1% in 2024, driven by the higher margin profile of the Evolve product line and manufacturing improvements.","length":160,"tagName":"p"}]},{"val":[{"type":"text","content":"Net loss for 2025 was $6.4 million compared to $6.2 million in 2024. 2025 included $631,000 in one-time legal expenses and $135,000 in non-cash operating lease expense. Excluding these items, Adjusted Net Loss would have been $5.6 million.","length":239,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITD...